K. Pritchard

1.9k total citations
22 papers, 444 citations indexed

About

K. Pritchard is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, K. Pritchard has authored 22 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in K. Pritchard's work include Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (6 papers) and Estrogen and related hormone effects (6 papers). K. Pritchard is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (6 papers) and Estrogen and related hormone effects (6 papers). K. Pritchard collaborates with scholars based in Canada, United States and United Kingdom. K. Pritchard's co-authors include Carol Sawka, Leonard Reyno, E. Chouinard, Susan Dent, Andrew R. Willan, Amiram Gafni, Mark Levine, Timothy J. Whelan, Richard Tozer and Hakam Abu-Zahra and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Journal of Clinical Epidemiology.

In The Last Decade

K. Pritchard

22 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Pritchard Canada	10	216	142	139	109	85	22	444
Nicholas Zdenkowski Australia	15	294 1.4×	115 0.8×	166 1.2×	192 1.8×	90 1.1×	59	597
W. Li United States	8	428 2.0×	106 0.7×	54 0.4×	77 0.7×	90 1.1×	9	682
Brionna Y. Hair United States	10	260 1.2×	130 0.9×	80 0.6×	87 0.8×	62 0.7×	25	498
Paula Trahan Rieger United States	13	221 1.0×	71 0.5×	101 0.7×	128 1.2×	151 1.8×	45	652
M Baum United Kingdom	10	253 1.2×	140 1.0×	73 0.5×	51 0.5×	266 3.1×	24	481
Rachel Yang United States	13	198 0.9×	122 0.9×	45 0.3×	84 0.8×	25 0.3×	34	554
Marjory Charlot United States	13	319 1.5×	172 1.2×	57 0.4×	52 0.5×	66 0.8×	35	544
Isra Levy Canada	13	171 0.8×	61 0.4×	87 0.6×	102 0.9×	36 0.4×	20	558
AH Partridge United States	6	307 1.4×	143 1.0×	67 0.5×	77 0.7×	94 1.1×	30	754
E. Chouinard Canada	5	180 0.8×	58 0.4×	143 1.0×	91 0.8×	42 0.5×	12	424

Countries citing papers authored by K. Pritchard

Since Specialization

Citations

This map shows the geographic impact of K. Pritchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Pritchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Pritchard more than expected).

Fields of papers citing papers by K. Pritchard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Pritchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Pritchard. The network helps show where K. Pritchard may publish in the future.

Co-authorship network of co-authors of K. Pritchard

This figure shows the co-authorship network connecting the top 25 collaborators of K. Pritchard. A scholar is included among the top collaborators of K. Pritchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Pritchard. K. Pritchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gray, R, K. Pritchard, Kathy S. Albain, et al.. (2015). 5BA Prospective trial of endocrine therapy alone in patients with estrogen-receptor positive, HER2-negative, node-negative breast cancer: Results of the TAILORx low risk registry. European Journal of Cancer. 51. S714–S714. 1 indexed citations

Sgroi, Dennis C., Erin Carney, Elizabeth Richardson, et al.. (2011). Prediction of late recurrences by breast cancer index in the NCIC CTG MA.17 cohort.. Journal of Clinical Oncology. 29(27_suppl). 2–2. 2 indexed citations

Cheang, Maggie C.U., Stephen Chia, Dongsheng Tu, et al.. (2009). Anthracyclines in basal breast cancer: The NCIC-CTG trial MA5 comparing adjuvant CMF to CEF. Journal of Clinical Oncology. 27(15_suppl). 519–519. 40 indexed citations

Goodwin, Pamela J., Marguerite Ennis, K. Pritchard, J. Koo, & Nicky Hood. (2008). Frequency of vitamin D (Vit D) deficiency at breast cancer (BC) diagnosis and association with risk of distant recurrence and death in a prospective cohort study of T1–3, N0–1, M0 B. Journal of Clinical Oncology. 26(15_suppl). 511–511. 24 indexed citations

Pritchard, K., Joan Francesc Julián Ibáñez, David R. McCready, et al.. (2008). A prospective study evaluating ¹⁸F-Fluorodeoxyglucose (¹⁸FDG) positron emission tomography (PET) in the assessment of axillary nodal spread in women undergoing sentinel lymph node biopsy (SLNB) for breast cancer. Journal of Clinical Oncology. 26(15_suppl). 533–533. 2 indexed citations

Dent, R., K. Pritchard, Wahid T. Hanna, et al.. (2007). P46 Patterns of recurrence and prognosis in women with basal-like breast cancer. The Breast. 16. S25–S25. 1 indexed citations

Grunfeld, Eva, Jim A. Julian, K. Pritchard, et al.. (2006). A randomized controlled trial (RCT) of long-term follow-up for early stage breast cancer comparing family physician to specialist care: A report of secondary outcomes. Journal of Clinical Oncology. 24(18_suppl). 6003–6003. 2 indexed citations

Goodwin, Pamela J., Marguerite Ennis, K. Pritchard, et al.. (2004). Association of young age and chemotherapy with psychosocial distress and health-related quality of life (HRQOL) during the first year after breast cancer (BC). Journal of Clinical Oncology. 22(14_suppl). 8014–8014. 5 indexed citations

Grunfeld, Eva, Michael A. Levine, Jim A. Julian, et al.. (2004). A randomized controlled trial (RCT) of routine follow-up for early stage breast cancer: A comparison of primary care versus specialist care. Journal of Clinical Oncology. 22(14_suppl). 665–665. 10 indexed citations

10.

Whelan, Timothy J., Carol Sawka, Mark Levine, et al.. (2003). Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer. JNCI Journal of the National Cancer Institute. 95(8). 581–587. 185 indexed citations

11.

Glück, Stefan, Michael Crump, MN Levine, et al.. (2001). A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study. European Journal of Cancer. 37. S285–S285. 21 indexed citations

12.

Pritchard, K.. (2001). The role of tamoxifen and aromatase inhibitors/inactivators in postmenopausal patients.. PubMed. 7(12 Suppl). 4356s–4359s; discussion 4411s. 3 indexed citations

13.

Swain, Sandra M., et al.. (1999). Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 4: Urogenital atrophy, vasomotor instability, sleep disorders, and related symptoms.. PubMed. 13(4). 551–4, 557. 7 indexed citations

14.

Crump, Michael, Carol Sawka, Gerrit DeBoer, et al.. (1997). An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer. Breast Cancer Research and Treatment. 44(3). 201–210. 49 indexed citations

15.

Goss, Paul E., Karen Gelmon, Leona Rudinskas, et al.. (1997). Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer. Cancer Chemotherapy and Pharmacology. 41(1). 53–60. 3 indexed citations

16.

Hull, D., et al.. (1996). Metabolic rate of sleeping infants.. Archives of Disease in Childhood. 75(4). 282–287. 8 indexed citations

17.

Pritchard, K., H. Lavina A. Lickley, B.G. Mobbs, et al.. (1995). The Henrietta Banting Breast Centre database: A model for clinical research utilizing a hospital-based inception cohort. Journal of Clinical Epidemiology. 48(6). 779–786. 13 indexed citations

18.

Vandenberg, Theodore A., K. Pritchard, E. Eisenhauer, et al.. (1993). Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study.. Journal of Clinical Oncology. 11(7). 1241–1244. 26 indexed citations

19.

Mobbs, B.G., Wedad Hanna, K. Pritchard, et al.. (1993). The standardization of estrogen receptors. The Journal of Steroid Biochemistry and Molecular Biology. 45(5). 367–373. 14 indexed citations

20.

Ginsburg, A D, et al.. (1989). Systemic adjuvant therapy for node-negative breast cancer.. PubMed. 141(5). 381–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact